I told my doctors I got the 23andMe test, and it just blew their minds. Celiac Disease (Genetic Health Risk Report)*


Celiac Disease (Genetic Health Risk Report)*

Charlie’s story began in college when he abruptly lost about 40 lbs in one month. After his doctor ran several tests, Charlie learned he had ulcerative colitis, so he took medications and changed his diet to manage his symptoms. Still, he never felt completely better. Despite years of appointments, treatments, and tests, his doctors could only assure him that his condition was in remission.

When Charlie’s wife gave him a 23andMe Health + Ancestry Service kit, he found out that he was at increased risk for developing celiac disease. He took his 23andMe report to his doctors for follow-up testing and found out that he did, in fact, have celiac disease. “Without 23andMe, I’m not sure how I would have ever uncovered the truth about my condition.”

After his diagnosis, Charlie made lifestyle changes suggested by his doctor, like cutting out gluten. While some changes have been difficult, Charlie is grateful 23andMe help him take control of his health.

Learn More
Sample report: 1 variant, 1 copy (HLA-DQB1)
All Available Reports: Click here

See Additional Customer Stories

*The 23andMe PGS test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child’s risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. Warnings & Limitations: The 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants) is indicated for reporting of the 185delAG and 5382insC variants in the BRCA1 gene and the 6174delT variant in the BRCA2 gene. The report describes if a woman is at increased risk of developing breast and ovarian cancer, and if a man is at increased risk of developing breast cancer or may be at increased risk of developing prostate cancer. The three variants included in this report are most common in people of Ashkenazi Jewish descent and do not represent the majority of BRCA1/BRCA2 variants in the general population. This report does not include variants in other genes linked to hereditary cancers and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact cancer risk. The PGS test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. For important information and limitations regarding other genetic health risk reports and carrier status reports, visit https://www.23andme.com/test-info/ .